GlassScriptPhysician profile
Patrick J Woodman
NPI 1750369757
$3,361.04
in general payments reported to CMS, 2019-2025
23 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $87.64 · 2021: $1,799 · 2022: $136 · 2023: $214 · 2024: $497 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,300.73 | 2021-2024 | Restorelle |
| Sumitomo Pharma America, INC. | $290.87 | 2023-2025 | Gemtesa |
| Caldera Medical, INC | $276.12 | 2021-2025 | Desara |
| Axonics, INC. | $223.71 | 2020-2024 | Axonics, Bulkamid |
| Coopersurgical, INC. | $210.48 | 2019-2021 | |
| 180 Medical, INC. | $186.81 | 2024-2025 | Cure Catheter |
| Hologic INC | $129.04 | 2021 | |
| Minerva Surgical, INC | $117.31 | 2021 | |
| Abbvie INC. | $106.90 | 2021 | |
| Medtronic, INC. | $91.59 | 2023-2025 | Interstim, Altaviva |
| Baxter Healthcare | $73.37 | 2020 | |
| Allergan, INC. | $60.32 | 2019-2021 | |
| Astellas Pharma US INC | $49.20 | 2023-2024 | Veozah |
| Boston Scientific Corporation | $41.79 | 2023-2025 | Axonics |
| Femselect INC. | $38.40 | 2025 | Enplace |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma Global Development | $33.32 | 2025 | Veozah |
| Biogen, INC. | $25.56 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $20.97 | 2019 | |
| Olympus America INC. | $20.09 | 2023 | Olympus |
| Bayer Healthcare Pharmaceuticals INC. | $18.99 | 2019 | |
| Urovant Sciences INC | $17.68 | 2022 | |
| Therapeuticsmd, INC. | $15.81 | 2019 | |
| Amgen INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Woodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.